ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Tasigna 150 mg, Kapseln - 112 Kapsel(n)
58007004 Novartis Pharma Schweiz AG
Tasigna 150 mg, Kapseln24.07.2007
  24.08.2010
Nilotinib (L01EA03) 
WHO-DDD 
07.16.10.112 Kapsel(n)
07.16.10. 
A  
Yes 
IPCI
1876.76Yes
    
10 %2057.50
  
7680580070049Synthetika
4687488 
Composition
nilotinibum 150 mg ut nilotinibi hydrochloridum monohydricum, lactosum monohydricum 117.08 mg, crospovidonum, poloxamerum 188, silica colloidalis anhydrica, magnesii stearas, Kapselhülle: gelatina, E 171, E 172 (rubrum), E 172 (flavum), Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammoniae solutio 28 per centum, pro capsula.
Packungsbestandteile
Capsules 
 
Active AgentDose
Nilotinibum150 mg
BAG: Active AgentDose
Nilotinibum150 mg
 
Inactive agentsDoseadditional_information
(Flavum)  
(Nigrum)  
(Rubrum)  
Ammoniae Solutio28  
Crospovidonum  
E 171 color.
E 172 color.
Gelatina Kapselhülle
Lacca Drucktinte
Lactose Monohydrate117.08 mg 
Magnesii Stearas  
Per Centum  
Poloxamer188  
Pro Capsula  
Propylenglycol  
Silica Colloidalis Anhydrica  
 
Source
Data was imported : 04.12.2021 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home